Fred Callori - 27 Aug 2021 Form 4 Insider Report for Landos Biopharma, Inc.

Role
Director
Signature
/s/ Eric W. Blanchard, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
27 Aug 2021
Net transactions value
$0
Form type
4
Filing time
31 Aug 2021, 16:04:57 UTC
Previous filing
02 Jun 2021
Next filing
18 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LABP Stock Option (right to buy) Award $0 +36,000 $0.000000 36,000 27 Aug 2021 Common Stock 36,000 $14.18 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of common stock underlying this option will vest and become exercisable in 36 equal monthly installments beginning on August 27, 2021, subject to the Reporting Person's continuous service with the Issuer on each such date.